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Abstract
Two gene expression profiling studies designed to identify maternal influences on development of the neonate immune
system and to address the population structure of the leukocyte transcriptome were carried out in Brisbane, Australia. In the
first study, a comparison of 19 leukocyte samples obtained from mothers in the last three weeks of pregnancy with 37
umbilical cord blood samples documented differential expression of 7,382 probes at a false discovery rate of 1%,
representing approximately half of the expressed transcriptome. An even larger component of the variation involving 8,432
probes, notably enriched for Vitamin E and methotrexate-responsive genes, distinguished two sets of individuals, with
perfect transmission of the two profile types between each of 16 mother-child pairs in the study. A minor profile of variation
was found to distinguish the gene expression profiles of obese mothers and children of gestational diabetic mothers from
those of children born to obese mothers. The second study was of adult leukocyte profiles from a cross-section of Red Cross
blood donors sampled throughout Brisbane. The first two axes in this study are related to the third and fourth axes of
variation in the first study and also reflect variation in the abundance of CD4 and CD8 transcripts. One of the profiles
associated with the third axis is largely excluded from samples from the central portion of the city. Despite enrichment of
insulin signaling and aspects of central metabolism among the differentially expressed genes, there was little correlation
between leukocyte expression profiles and body mass index overall. Our data is consistent with the notion that maternal
health and cytokine milieu directly impact gene expression in fetal tissues, but that there is likely to be a complex interplay
between cultural, genetic, and other environmental factors in the programming of gene expression in leukocytes of
newborn children.
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Introduction
A growing body of evidence points toward a fetal origin for
influences on chronic disease susceptibility, in part reflecting
transmission of maternal health effects [1] Most apparent for
conditions such as Fetal Alcohol Syndrome, maternal influences are
now also implicated in childhood obesity and early onset Type 2
Diabetes. Barker’s thrifty phenotype hypothesis [2–3] argues that
genetic reprogramming occurs in fetuses developing in undernour-
ished mothers, preparing them for rapid assimilation of nutrients
that turns out to be inappropriate when food is actually readily
available. On the other hand, obese mothers tend to give birth to
overweight children, even after adjusting for genetic correlations
[4]. The mechanism of any genetic reprogramming is unknown, but
seems likely to involve epigenetic modification of the chromatin
[5–7] and to be reflected in changes in gene expression profiles that
should be observable already in newborn babies.
Umbilical cord blood is an appropriate tissue to look for such
effects, since it is readily obtained at birth and can be sampled
from populations. A study in Thailand, for example, detected the
influence of maternal exposure to arsenic in altered profiles of cord
blood gene expression [8]. Despite the extensive literature on the
development of immune competence in babies and its relevance to
cord blood transplantation [9–11], profiling of leukocyte gene
expression in newborns is in its infancy. A recent study of 30
mother-child pairs from the Czech Republic reported 2-fold
differential expression of 841 genes involved in multiple immunity-
related pathways [12]. Likewise, Jiang et al [13–14] have also
documented up-regulation of interferon and interleukin signaling
in maternal relative to cord blood monocytes and dendritic cell
samples from small numbers of donors; these studies also described
differences in immune competence assessed by LPS challenge.
Differences in adult peripheral blood expression have also been
documented between mothers who did or did not transmit HIV to
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their children [15], but there is a dearth of information on the
population structure of maternal and neonate gene expression
profiles.
The advent of genomic profiling tools has nevertheless enabled
systematic evaluation of the genetic influences on the expression of
individual genes in adult peripheral blood monocytes. Two
notable studies involving approximately 1,000 participants in
Icelandic [16] and Mexican American cohorts [17] have
documented correlations between gene expression and obesity as
well as serum cholesterol levels, respectively. Our own studies in
Morocco [18–19] have established that over a third of the
leukocyte transcriptome is altered in adult samples from nomads,
rural villagers, and urban residents, mediated in part by a complex
influence of gender-specific cultural practices. We also found that
genetic regulatory influences are robust to the environmental
sources of variance such that regulatory polymorphisms exert the
same influence on transcript abundance across locations and in
both Arab and Berber ethnicities [19]. Others have also
documented long-term environmental/cultural influences on adult
gene expression: for example, low levels of early-life stress
correlated with socioeconomic status are reflected in exaggerated
inflammatory response fifty years later, inferred from peripheral
blood monocyte gene expression profiles [20].
In this study, we extend the description of the population
structure of leukocyte gene expression profiles to a large
cosmopolitan city, including maternal and new-born cord blood
samples, to address three questions: (i) is there evidence of maternal
transmission of profiles to their babies, (ii) does any such
transmission differ between obese, normal weight, and gestational
diabetic mothers, and (iii) how are these influences distributed across
regions of the city? We conducted two sequential studies in Brisbane
(Queensland, Australia), a modern city of 2 million people with
marked socio-economic differences between residents living in the
central business district, along the scenic Brisbane River, in
sprawling suburbs, and in outlying rural communities. The first
study contrasting leukocytes from late-term pregnant women and
their newborn children provides strong evidence for transmission of
two classes of gene expression profile that are orthogonal to the
differentiation of maternal and cord blood samples. The second
study evaluating leukocyte gene expression profiles of 100 Red
Cross blood donors confirmed that two less prominent axes of
variation in the mother-newborn comparison are more generally
seen in gene expression profiles of Red Cross blood donors, one of
which is the similar to the major component of variation
distinguishing rural and urban residents in southern Morocco
[19], while a hint of geographic structure was also evident in the
sample. These data confirm that peripheral blood gene expression
does vary somewhat discretely even in urban populations, in part
reflecting metabolic phenotypes of the adult population, with
implications for early influences on susceptibility to chronic disease.
Results
Mother-Newborn Study
The leukocyte gene expression profiling dataset for the mother-
newborn study consisted of 56 individuals, with 19 mothers
sampled in the last month of pregnancy and 37 cord blood samples
from newborn babies. Nine of the mothers were overweight, most
of whom had BMI values over 30 (before pregnancy) and hence
were classified as obese. From the 37 children, 11 were born to
obese mothers, 8 to gestational diabetic mothers (with a wide
range of body mass indices), and 18 to normal-weight mothers.
There were 16 mother-newborn pairs (that is, 32 of the 56
individuals) in the dataset.
After normalization and adjustment for RNA integrity, we
examined the patterns of relatedness among individuals, first by
clustering the overall profiles. As shown in Figure 1A, there are two
clearly visible levels of clustering. The highest level distinguishes two
types of profile, labeled BP1A and BP1B, and analysis of variance
indicates that 8,428 transcripts differ between these two groups of
individuals at a false discovery rate of 1% (and 3,983 transcripts at
p,1025). Within each of BP1A and BP1B, there is also clear
separation of the profiles of mothers and newborns; ANOVA
identifies 7,370 transcripts of this class at the 1% FDR (3,475 at
p,1025). There was no evidence for any influence of generation on
the BP1 profile as fewer probes than expected by chance show an
interaction effect at any level of significance. This implies that
whatever factors drive the differentiation of BP1A and BP1B are
independent of those that distinguish mothers and newborns, and
influence non-overlapping suites of genes.
The two BP1 profiles do not correlate with any epidemiological
covariates that we have considered: they are not representative of
maternal weight or age, and only a handful of the mothers had
health conditions that might have modified their expression
profiles. Astonishingly, though, we observed perfect transmission
of the two profiles from mother to newborn: all 7 BP1A mothers
with newborns in the dataset had BP1A newborns, and all 9 BP1B
mothers had BP1B newborns. This result indicates a strong
tendency to inheritance of overall leukocyte gene expression
profiles, but our data does not establish whether the mechanism is
genetic or environmental. Nor is it clear whether the profiles are
stably retained through the lifetime of the individuals.
A more formal quantitative genetic test of inheritance was
performed by indexing each of the 16 mother-newborn pairs with
a parameter indicating their familial relationship. An ANOVA on
this reduced dataset of 32 individuals showed that the pair index
explains half of the variance in the first principal component of
transcript abundance, suggesting very high heritability. However,
this approach almost certainly over-estimates the genetic contri-
bution since environmental factors likely contribute to the
separation of BP1A and BP1B, thereby contributing to the
observed similarity between parent and child. If it is instead
assumed that this separation is entirely due to environment, then
the minimal genetic contribution can be estimated as the
proportion of variance explained by the pair index when both
generation, and BP1A or BP1B status, are included in the model.
When this is done, BP1 status explains 45% of the variance in gene
expression, while the mother-child pair index explains just 3%,
indicating that shared inheritance only explains a small proportion
of the variance within the two BP1 profiles. In other words, within
BP1A or BP1B, mothers and newborns only share slightly more
similar profiles than randomly chosen pairs of individuals, but the
clear differentiation of these classes nevertheless represents very
strong transmission of leukocyte expression from mother to
newborn. It is not possible from these analyses to infer the true
contribution of genotype to the separation between the profiles.
We next performed principal component (PC) analysis on the
full dataset, and observed that the first five PC explain 50% of the
total variance in gene expression. PC1MN (16.9%) corresponds to
the BP1A versus BP1B difference, while PC2MN (15.9%)
corresponds to the Mother-Newborn distinction (Figure 2A).
The next three PC explain 8.4%, 5.5% and 4.0% of the variance
respectively. The numbers of probes significantly associated with
each PC are reported in Table 1. None of the PC are significantly
associated with maternal body weight, although a suggestion that
PC4MN reflects metabolic status is indicated in Figure 2B, which
shows that newborn babies of obese mothers typically have
positive values of PC4MN (green spots), while obese mothers
Maternal-Fetal Gene Expression
PLoS ONE | www.plosone.org 2 December 2010 | Volume 5 | Issue 12 | e14479
(orange spots) all have negative values of PC4MN. This contrast is
significant (p = 0.002, 2-tailed Fisher’s exact test), and implies a
switch in this profile between maternal and cord blood.
Intriguingly, babies of gestational diabetic mothers (purple spots)
also tend to have negative values of PC4 (p = 0.02, 2-tailed Fisher’s
exact test). Normal mothers and newborns are not indicated on
Figure 2B as they cover the full range of values for PC3MN and
PC4MN. PC5MN is specific for some of the newborn babies, one
third of whom have lower values than any of the mothers.
Red Cross Study
In order to determine whether the expression profiles
differentiating pregnant women and their babies are also present
in a general population of adults in Brisbane, we generated similar
profiles for a sample of 100 Red Cross blood donors. Hierarchical
clustering (Figure 1B) and principal component analyses once
again identified major axes of variation, but in this case the first
three axes, PC1RC, PC2RC, and PC3RC explain just 10.9%, 8.3%
and 5.6% of the variance respectively. We obtained BMI measures
for all donors, and assayed for presence or absence of
cytomegalovirus and Epstein-Barr virus infection, but none of
these factors were correlated with the PC axes of variation.
Although the two samples were collected at different times, and
processed independently, there is highly significant overlap in the
patterns of differential gene expression associated with the
common axes of variation. This is seen in evaluation of the
correlation between the slopes of the multiple regression co-
efficient for each PC (Table 2) and Figure 3 for PC3MN and
PC1RC, and for PC4MN and PC2RC. Note that PC2MN
corresponds to the mother-newborn distinction that is not present
Figure 1. Correlation structure of leukocyte profiles. Heat maps show overall strength of pairwise correlation between pairs of profiles (red,
high positive, blue, high negative). (A) In the mother-newborn study, clusters of samples obtained from cord blood (red lines) and maternal (blue
lines) are clearly evident within the two larger clusters, BP1A and BP1B. (B) In the Red Cross study, two large clusters are observed that are unrelated
to gender (blue, male; green, female) with further structure visible within both major clusters.
doi:10.1371/journal.pone.0014479.g001
Figure 2. Principal Components (PC) of expression variation in the Mother-Newborn study. (A) PC2MN cleanly separates maternal (red)
and cord blood (blue) samples, but an even greater proportion of the variation and separation of profiles is observed for PC1MN, which defines the
BP1A (dark) and BP1B (light) types discussed in the text. (B) PC3MN is not associated with any measured phenotypic variable, but PC4MN largely
distinguishes cord blood of obese children (green) and gestational diabetic children (purple), while maternal blood (orange) also has negative values
of PC4MN.
doi:10.1371/journal.pone.0014479.g002
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in the Red Cross study. Surprisingly, PC1MN was not highly
correlated with any of the axes in the Red Cross study, although
many of the most divergent genes between the profiles also
contribute to differentiation in the other components. PC5MN and
PC3RC do not correspond to one another. There are 1239 genes
significantly correlated with both PC3MN and PC1RC at p,10
25,
the vast majority of which are up-regulated 2-fold or more in half
the individuals. For the axis corresponding to PC4MN and PC2RC,
there are 656 transcript probes in common at p,1025, each of
which shows the same direction of differential expression in the
two studies (291 down and 365 up).
BP1A and BP1B are distributed randomly across the geography
of Brisbane, but the profiles associated with PC3RC show a non-
random distribution as shown in Figure 4. One of the profiles,
indicated by the red dots, is excluded from the central portion of
the city along the Brisbane River (p=0.005, 2-tailed Fisher’s exact
test), while the other is found throughout the city and surrounding
regions. This tendency is noteworthy given a socio-economic
differentiation between the city and riverfront (which tend to be
more affluent) and outlying suburbia. Obesity levels are not
significantly different between the two parts of the city in the
sample, and do not associate with the two profiles (p=0.88, t-test).
Moreover, the profile observed to switch between the obese
mothers and their babies in the first study, corresponding to
PC2RC, is not geographically structured in this study. All principal
component loadings and significance values are listed in Table S1.
Gene Content of the Profiles
Gene Ontology analysis summarized in Table 3 generally
identified broad classifications of gene function as responsible for
the major axes of variation, with the most significant terms
involving intracellular protein trafficking, protein modification,
and organellar biogenesis. A sharp contrast was observed in the
differentiation between maternal gene expression and cord blood
leukocytes, which largely involves a variety of immune pathways,
cytokine signaling, and antiviral defense, as noted by Merkerova
et al. [12] and Jiang et al. [13–14]. We observed higher expression
(p,1025) in maternal than cord blood of transcripts related to
Interleukin (17 genes vs 5 genes) and Interferon (15 vs 3) signaling,
as well as of Toll-like receptors (7 vs 0) and the TRIM family of
protein-degradation enzymes (13 vs 4). Similar numbers of CD
and C-lectin transcripts were differentially expressed in mothers
and newborns, but cord blood shows higher expression of MRP
multidrug resistance genes (21 vs 1), ribosomal proteins (16 vs 0
RPS and RPL genes), WD-repeat genes (11 vs 2), the MCM
replication initiator complex (7 vs 0), EIF translation initiator
proteins (11 vs 3) and NDUF complex NADH: ubiquinone
oxidoreductases (13 vs 1). These results are consistent with the
notion that the leukocyte population in newborns is poised for
expansion, while adult leukocytes are more prepared to mount an
immune response. Differential expression values are also provided
in Table S1.
Notably too, the major axis of variation in Brisbane adults
(PC1RC and PC3MN) is highly enriched for oxidative phosphory-
lation and ribosomal protein genes. This axis is reminiscent of the
major axis of variation differentiating rural and urban residents in
southern Morocco [19], although the involvement of SNORD family
RNAs seen there was not observed in Brisbane. The second axis
(PC2RC), corresponding to the module that apparently switches
between obese mothers and their children (PC4MN) is exceptional in
showing no enrichment for general cellular processes, but rather
identifies differential expression of the T cell receptor complex and
signaling components, as well as of CD8 transcripts.
No formal statistical relationship between body mass index, body
weight, or gestational diabetes and the expression of individual
genes was observed, but targeted analysis of specific pathways hints
that there is some connection between metabolic status and
leukocyte gene expression. Among the most highly represented
KEGG pathways in several of the signatures are insulin signaling,
and various aspects of central metabolism. Monocytes and
macrophages are major targets and producers of IGF-1, which is
implicated in cardiovascular, metabolic, and lung disease [21], but it
is the IGF2R receptor transcript that is most strongly associated with
the principal components of expression in both studies. Functional
variation in the IGF pathway seems a promising target for focused
evaluation of the personal health implications of peripheral
biomarkers and their response to environmental agents such as
smoking and diet. Indeed, this theme is reinforced with the
differential expression of multiple genes in KEGG pathways
involved in cell-environment (focal adhesion/actin cytoskeleton,
MAPK and neuronal disease pathways) and cell-proliferation
processes (Cancer, AML and MAPK pathways).
We also used the ToppGene suite [22] to search for over-
representation of predicted transcription factor binding sites
Table 1. Numbers of genes significantly differentially expressed in each profile.
Significance Level Mother-Newborn Study Red Cross Study
BP1 M-N PC3MN PC4MN PC5MN PC1RC PC2RC PC3RC
p,1025 3983 3475 2906 1253 363 4769 3100 1866
q,0.01 (FDR 1%) 8428 7370 6613 5016 3264 9096 7149 5789
p,0.05 10107 9059 8049 6609 4915 10095 8345 7065
BP1 and M-N are categorical contrasts; all other are regression of expression on the PC.
doi:10.1371/journal.pone.0014479.t001
Table 2. Similarities between PC axes in the two studies.
PC1MN PC2MN PC3MN PC4MN PC5MN PC1RC PC2RC PC3RC
PC1MN 0 0 0 0 0.08 0.23 0.02
PC2MN 0 0 0.19 0.18 0 0.32 0
PC3MN 20.03 20.08 0 0 0.29 0.05 0.06
PC4MN 0 21 0.03 0.04 0 0.39 0.03
PC5MN 0.01 20.74 20.04 0.15 0.02 0.16 0.08
PC1RC 20.28 0.03 20.97 0.11 0.33 0 0
PC2RC 20.56 2.07 0.35 21.01 20.84 0 0
PC3RC 20.11 0.03 0.29 20.2 0.45 20.01 0.03
Adjusted R-squared above diagonal; Slope of regression below.
doi:10.1371/journal.pone.0014479.t002
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and/or microRNA binding sites in the genes that account for each
principal component of variation. As a measure of robustness, we
looked for enrichment both in the top 1000 most significant
genes for each PC, and for all genes with p,1025 (Table S4).
Three transcription factors emerged as significant for BP1 in
the mother-newborn dataset: ELK1, NRF1, and ETS2 with
113, 82 and 84 targets respectively, while another 5 transcription
factors were significant only in the top 1,000 gene set. Two
micro-RNAs, miR-206 and miR-1 each had 50 differentially
expressed targets among the approximately 400 known transcripts
with predicted 39 UTR binding sites. Figure 5 shows a cluster
analysis of these genes, and also indicates (in yellow) a suite of
transcripts that are known to be responsive to methotrexate, which
is one of two drugs whose targets are significantly over-represented
in the top 1,000 most significant genes for BP1 (p,0.00002), the
other being Vitamin E. Various genes highlighted in brown
encode proteins involved in chromatin modification, including the
methyltransferase DNMT1.
ToppGene suggested enrichment for transcription factor target
sets in PC3MN and for PC4MN, both also implicated in regulation
of BP1 (PC1MN), namely ELK1 and ETS2 respectively. No
miRNA were consistently associated with these PC, or with
PC2MN, which distinguishes maternal and cord blood. However,
each of PC3MN and PC4MN are enriched for suspected targets of
over 50 compounds, most of which are unique for each PC,
including such toxins as paraquat, arsenic and ozone; drugs such
as Thalidomide, Hydralazine, and Valproic acid; and herbicides
including Clofibric acid, Isoproturon, and Atrazine. Furthermore,
the association of PC4MN with metabolic regulation is supported
by the significant enrichment for altered expression of 19 of the 68
genes annotated in the Reactome ‘‘metabolism of sugars’’
pathway, including such enzymes as G6PD, GAPDH, and
PGK1. Many other potential targets of a half dozen transcription
factors and 35 microRNAs were associated with the major PC of
the Red Cross blood donor dataset.
Discussion
The Structure of Leukocyte Gene Expression Variation in
Brisbane
We document a considerable degree of population structure in a
diverse adult population of residents of a large city in a developed
country, extending our previous finding that over a third of the
leukocyte transcriptome differs between urban and rural residents
of Morocco [18]. Four aspects of the analysis are particularly
noteworthy: (1) the first principal component in mothers and
newborns is unique to these individuals, but overlays two
additional components of variation that were replicated in our
study of adults blood donors; (ii) the unique profile reflecting CD4
transcript abundance appears to be faithfully transmitted from
pregnant mothers to their newborn children; (iii) a profile
involving several hundred genes may differentiate newborn babies
of obese and gestational diabetic mothers; and (iv) a minor
component of variation also shows a hint of demographic
differentiation between the city itself and surrounding suburbs.
Gene expression differences in a complex cell population such as
peripheral blood leukocytes are likely to reflect differences both in
the relative abundance of major cell types (such as lymphocytes,
neutrophils, and macrophages), and differential expression within
cells. Platelets and erythrocytes were removed by filtration during
sampling, but the leukocyte samples are nevertheless diverse, so we
also estimated the number of cells expressing various CD (cellular
differentiation) antigens by flow cytometry for half of the adult blood
donor sample. CD8 transcript and cell counts were highly
correlated (n= 47; p,0.0001 for each of 6 different CD8A and
CD8B probes), but this was not true of CD4 (p= 0.08 for the single
probe) and hence the ratio of these cell types is not directly reflected
in the ratio of transcript levels. This probably reflects the diversity of
CD4+ cells, as well as the fact that cell counts are independent of
marker intensity. Unfortunately, we did not have FACS data or
complete blood counts for the mother-newborn study and cannot
conclude whether the expression divergence reflects altered
fractions of contributing cell types.
Independent evidence that differences in cellular abundance
contribute to expression variation can be seen by evaluating the
correlation structure of transcript abundance across all of the 103
CD, 26 C-type lectin, and 11 Toll-like receptor probes that showed
expression above background. Modulated modularity clustering
[23] of these profiles in both datasets revealed eight strongly co-
regulated groups of transcripts (Figure 6). These also cluster for the
most-part in our Moroccan dataset (not shown), and are
recapitulated using classical hierarchical clustering with the
difference that positively and negatively co-varying transcripts
cluster together in the MMC analysis. The largest cluster (Cluster
Figure 3. Similarity of major axes of variation in the two studies. (A) Scatterplot of PC loadings for PC3MN and PC1RC: slope = 0.69, R
2= 0.35,
although a large number of uncorrelated probes are also observed (-2,PC3MN ,2) (B) Scatterplot of fold PC loadings for PC4MN and PC2RC:
slope = 0.72, R2= 0.37.
doi:10.1371/journal.pone.0014479.g003
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1) includes most of the TLR, CLEC4E, and ten CD genes including
CD4; CD8 clusters with CD2 and CD3D,G; and the other major
CD clusters are listed in Table 4. Such clustering can be readily
explained assuming that the respective transcripts are indicative of
common cell surface protein expression on particular differentiated
cell types. The analysis also implies that genes in Clusters 4, 5 and 6
are expressed not just independently of, but to some extent to the
exclusion of those in Cluster 1. Co-regulation of the C-type lectin
and Toll-like receptors in cluster 1B (the most strongly correlated
transcripts represented by the bright red coloring in Figure 6) is likely
to have functional implications with respect to the ability to respond
to fungal and bacterial pathogens [24–25], particularly if the
recruitment of particular T-cell classes is affected by constraints on
gene expression that are seen in the observed correlation structure.
The transmission of the BP1A and BP1B profiles from mother to
newborn could conceivably reflect genetic or environmental
regulation of the abundance of cell types as well, though if the
effect were genetic it would be unlikely to be so clearly maternally
transmitted. CD4 to CD8 cell surface ratios have been shown to be
heritable in a large cohort of Brisbane adolescent twins [26–27], and
to be associated with Type 1 Diabetes as well as control of HIV
infection. In the present study the ratio of transcript abundance of
these two genes is extremely highly associated with BP1A or BP1B
profile (F1,54 = 58.8, p=3610
210), but this is mostly due to variation
in CD4 transcripts, while CD8 expression varies along the PC4MN
and PC2RC axes. Unexpectedly, the BP1 profile defined by PC1MN
is not observed in the more general adult cohort, raising the
possibility that it is unique to pregnant women and their children.
The possibility that it is a technical artifact of the analysis must be
considered, but it also dominates the profiles of only the individuals
with the highest quality RNA (see methods), it is hard to conceive
that an artifact would stably transmit across the generations, and
would so clearly correlate with a measure of differentiation of major
T cell classes. Each individual’s recent history of immune exposure
could conceivably shift the expression profiles between modes, but
since the fetal immune system is not thought to be responsive to
pathogens, our data suggests instead that some aspect of the
maternal environment that does cross the placenta barrier (such as
cytokine profiles, perhaps) has a major impact on leukocyte gene
expression in both the mother and newborn.
The major axis of variation documented here in the cross-
sectional adult study (PC1RC) appears to correspond to the major
axis we observed differentiating remote Berber villagers from
urban Moroccans using basically the same leukocyte sampling
Figure 4. Distribution of PC3RC-associated expression module across the city of Brisbane. Blue and Red dots correspond to individuals
with high and low values of PC3RC in the Red Cross study, superimposed on a GoogleMap of the city. There are 199 genes down-regulated and 209
upregulated at p,10-5 between two major profiles. Note that the blue profile is distributed throughout the city, while the red one is excluded from
the central business district (near South Brisbane on the map) and along the riverfront extending southwest to Indooroopilly. Green shading indicates
more rural regions surrounding the city, whereas yellow indicates suburban and high density areas. Blue is Moreton Bay, with the Pacific Ocean to the
east (right).
doi:10.1371/journal.pone.0014479.g004
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strategy [19]. In Brisbane, the separation is not obviously
geographically structured, indicating that the environmental factor
driving the qualitative differentiation is embedded in lifestyle
differences even among residents of a large modern city.
Enrichment of genes involved in oxidative phosphorylation and
ribosomal biogenesis is suggestive of cell growth and division,
consistent with the fact that although circulating monocytes and
macrophages are post-mitotic, peripheral T-cells will divide in
response to antigenic stimulation and neonate T-cells are highly
proliferative [28]. Another possible source of differentiation along
this axis is a direct impact of antioxidants and/or renal stress. It
should be emphasized as well that, although present in mothers,
this particular profile was not transmitted from mother to newborn
as it randomly assorts among the mother-baby pairs.
We did not observe the correlation of gene expression with
obesity reported in peripheral blood monocytes in a larger
Table 3. Enriched gene sets.
Category Term Count P Value Fold Enrich Benjamini
Mother-Newborn PC1 (BP1A versus BP1B)
GOTERM_CC_ALL GO:0005622,intracellular 510 1.09E-28 1.3 4.75E-26
GOTERM_CC_ALL GO:0044422,organelle part 209 9.82E-14 1.6 1.07E-11
GOTERM_BP_ALL GO:0044238,primary metabolic proc 376 1.36E-10 1.2 1.78E-07
GOTERM_BP_ALL GO:0015031,protein transport 64 2.19E-11 2.5 5.75E-08
GOTERM_BP_ALL GO:0016043,cell component biogen 159 2.99E-10 1.6 3.14E-07
GOTERM_CC_ALL GO:0043233,organelle lumen 66 7.91E-07 1.9 4.58E-05
GOTERM_CC_ALL GO:0005794,Golgi apparatus 51 8.66E-07 2.1 4.42E-05
GOTERM_BP_ALL GO:0006396,RNA processing 43 3.58E-08 2.6 1.34E-05
GOTERM_CC_ALL GO:0012505,endomembrane system 67 9.87E-07 1.9 4.76E-05
GOTERM_BP_ALL GO:0010467,gene expression 182 3.29E-06 1.4 7.85E-04
GOTERM_BP_ALL GO:0043687,post-translational mod 87 2.38E-05 1.6 0.004
Mother-Newborn PC2
GOTERM_BP_ALL GO:0002376,immune system process 70 6.92E-09 2.1 3.64E-05
GOTERM_CC_ALL GO:0005622,intracellular 350 1.38E-06 1.2 3.99E-04
SP_PIR_KEYWORDS antiviral defense 9 1.29E-05 8 0.0034
SP_PIR_KEYWORDS erythrocyte 6 7.11E-05 12.9 0.0108
Mother-Newborn PC3 and Red Cross PC1
GOTERM_CC_ALL GO:0033279,ribosomal subunit 45 4.63E-37 13.2 1.34E-34
GOTERM_CC_ALL GO:0044444,cytoplasmic part 167 1.23E-18 1.9 1.07E-16
KEGG_PATHWAY hsa00190:Oxidative phosphorylation 22 6.95E-08 4 6.99E-06
GOTERM_BP_ALL GO:0016043, cell component biogen 108 3.13E-08 1.7 3.29E-05
GOTERM_CC_ALL GO:0005773,vacuole 18 2.80E-05 3.4 9.36E-04
GOTERM_BP_ALL GO:0016192,vesicle-med transport 30 1.37E-05 2.5 0.0048
GOTERM_BP_ALL GO:0030029,actin filament process 18 3.05E-05 3.3 0.0094
GOTERM_BP_ALL GO:0006915,apoptosis 37 1.27E-04 2 0.0263
SP_PIR_KEYWORDS myristylation 8 4.20E-05 8.3 0.005
Mother-Newborn PC4 and Red Cross PC2
KEGG_PATHWAY hsa04660:T cell receptor signaling 14 1.22E-06 5.4 2.46E-04
GOTERM_CC_ALL GO:0042101,T cell receptor complex 5 7.53E-05 20.3 0.0322
GOTERM_CC_ALL GO:0001772,immunological synapse 6 4.22E-05 14.6 0.036
Red Cross PC3
GOTERM_CC_ALL GO:0005622,intracellular 283 1.25E-16 1.3 9.64E-14
GOTERM_CC_ALL GO:0044428,nuclear part 55 5.35E-10 2.5 7.74E-08
GOTERM_MF_ALL GO:0003723,RNA binding 45 2.08E-11 3.2 5.98E-08
GOTERM_BP_ALL GO:0044267,cellular protein metab 112 1.98E-08 1.6 3.46E-05
GOTERM_BP_ALL GO:0048523,neg. regulation cell proc 42 1.13E-04 1.9 0.0226
GOTERM_BP_ALL GO:0006915,apoptosis 33 7.97E-05 2.1 0.0188
GOTERM_BP_ALL GO:0015031,protein transport 32 2.09E-05 2.3 0.0064
GOTERM_BP_ALL GO:0007242,intracell signaling cascade 54 1.79E-05 1.8 0.0063
KEGG_PATHWAY hsa05220:Chronic myeloid leukemia 10 5.54E-05 5.6 0.0111
doi:10.1371/journal.pone.0014479.t003
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Icelandic cohort [16] In fact, we specifically tested for association
between individual transcripts and either BMI (in both studies)
or metabolic syndrome indicators (obesity, gestational diabetes,
normal weight in the mother-newborn study), but there was not an
excess of significant associations relative to random expectations. It
thus seems likely that the major environmental influences on gene
expression profiles are to some extent population-specific. Broader
sampling across a diversity of lifestyles will be required to detect
commonalities, and to define baseline levels of variation with
which to detect abnormality in specific cohorts.
The Maternal Origins of Disease
The original ‘thrifty phenotype’ hypothesis [2] was devised to
explain the observation of elevated rates of obesity and early onset
diabetes in children born to undernourished mothers. It suggested
that metabolic reprogramming occurs to prepare children for a
hostile nutritional world, and has given rise to a school of thought
that mismatches between maternal and external environments
commonly contribute to chronic disease [29–30]. More generally
still, it is now recognized that maternal health, independent of
genetics, is a major contributor to child development and the onset
of disease [1]. If this is true, then we would expect to see an
influence of maternal metabolic status already at birth, for
example in the profiles of expression in cord blood.
Our data provide some support for this idea. Most pointedly,
there is unambiguous transmission of the major maternal profile,
BP1A or BP1B, frommother to newborn. The separation of the two
profiles is actually stronger in the newborns than the mothers and
was not detected in the general male and female adult population
(although the most divergently expressed genes are enriched in the
second component of variation in the second cohort of adult blood
donors). At this point, we do not know to what extent the profile is
stably maintained through the life of an individual, and longitudinal
studies will be required to monitor this and ascertain whether there
is any prospective impact on the likelihood of development of
chronic disease. Importantly for a strict version of the thrifty
phenotype hypothesis, there is no correlation between BP1 status
and obesity or gestational diabetes, so the profile is not a
discriminative biomarker for these two metabolic diseases.
It may however be a contributor, since insulin signaling and sugar
metabolism are among the key regulated pathways and are also
affected by the minor axes of variation, one of which (PC4MN)
appears to distinguish babies born to obese and gestational diabetic
mothers (Figure 2B), albeit in a small sample to date. If replicated,
this observation would provide a compelling argument for
reprogramming of expression states in leukocytes, particularly given
the switch in status between obese mothers and their children. One
interpretation of our data is that obese mothers have adapted to
their metabolic status by shifting their own expression profile to a
more normal state that is also seen in children born to gestational
diabetic mothers who are unable to transmit the reprogramming
signal to their newborns. Normal weight mothers themselves do not
Figure 5. Cluster analysis of BP1 using the ToppGene Suite. The top 1,000 transcripts contributing to BP1 (PC1MN) were scanned for
significant enrichment of transcription factor and microRNA binding sites and targets of the major factors were clustered using Cytoscape. Red
hexagons show predicted targets of the transcription factors in light purple squares (ELK1, SP1, ETS2, NRF1, AP2 and YY1) as well as the micro RNAs in
dark purple squares (miR-206, miR-1, miR-506, miR-128A, and miR-122A). Dark brown and green boxes highlight chromatin modification factors
including DNA and histone methylases and acetyltransferases. Methotrexate-responsive genes are indicated in yellow.
doi:10.1371/journal.pone.0014479.g005
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show any tendency to have a specific profile, and nor do their
children (data not shown). Children born to mothers with the lowest
BMI in some cases had profiles similar to those of the children born
to obese mothers, consistent with the observation that both low and
high weight mothers are at risk of having children with early onset
metabolic syndromes. Importantly, the maternal risks are statistical
tendencies, so we do not necessarily expect strong correlation
between expression states in newborns and the development of
metabolic disease, and it may take samples of several thousand
mother-baby pairs to establish a relationship.
It would be premature to extrapolate from this pilot study to
conclude that maternal health impacts child health already through
reprogramming of gene expression in fetal tissues. However, our
analyses do provide the first genomic evidence that this may be the
case, and calls for replication in larger and more diverse settings.
The suggestion that differential expression of methotrexate-
responsive genes is common in pregnant mothers is also relevant
from to child health, since methotrexate inhibits tetrahydrofolate
production, and low levels of this vitamin B9 derivative are known
to cause spina bifida; most expectant mothers (including all in this
study) are encouraged to take folate-supplements to prevent this
condition. It is also interesting to contemplate the implications of the
different leukocyte gene expression profiles for immune function in
the first few months and years of life. Categorical differences in
immune profiles may contribute to susceptibility to the development
of inflammatory, autoimmune, and aberrant infectious disease
responses, and may impact on the use of cord blood cells in
transplantation.
Materials and Methods
Blood Collection and RNA extraction
This study was approved by Institutional Review Boards of the
University of Queensland and the Wesley Research Institute, and
was conducted with permission of the Red Cross Society of
Australia. Written informed consent was obtained from all
participants and informed assent was provided by parents of
newborn children. Blood was collected by venipuncture (or
extraction from the umbilical cord immediately after birth).
Within 2 minutes of sampling, between 5 and 10 ml of blood were
Figure 6. Consistent clustering of cell surface marker transcripts. The MMC optimal clustering procedure was used to identify groups of co-
regulated CD, C-type lectin, and Toll-like receptor transcripts in the two studies. Lines link the indicated clusters consisting of genes listed in Table 4.
Clusters 1B and 2B correspond to the more tightly co-expressed genes in the larger clusters seen in the figure. Color key indicates strength and sign
of correlations within and between clusters.
doi:10.1371/journal.pone.0014479.g006
Table 4. Co-expressed clusters of cell surface markers.
Cluster 1A CD4 CD3D CD3E CD37 CD74 CD99 CD164 CD320
Cluster 1B CD36 CD46 CD55 CD58 CD84 CD86 CD93 CD302
CLEC4A CLEC4D CLEC4E TLR1 TLR2 TLR4 TLR5 TLR6 TLR8
Cluster 2A CD14 CD48 CD53 CD68 CD97 CD99 CD300A CD300LB
Cluster 2B CD2AP CD2BP2 CD47 CD63 CD69
Cluster 3 CD19 CD22 CD40 CD72 CD79A CD79B CD83
Cluster 4 CD8A CD8B CD2 CD3D CD3G
Cluster 5 CD7 CD96 CD160 CD247
Cluster 6 CD1A CD1C CD200R1 CLEC10A
All clusters observed reported in this table were observed in both datasets.
A and B refer to subclusters within 1 and 2, and generally include positively or negatively correlated sets of transcripts.
doi:10.1371/journal.pone.0014479.t004
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washed through a LeukoLock size-fractionation filtration system
(Ambion/Applied Biosystems, Austin TX) that traps leukocytes
while allowing most platelets, erythrocytes, and serum to pass
through. Following manufacturer’s recommendations, the filters
were immediately infiltrated with RNAlater solution and stored
frozen at 220uC until preparation of RNA.
RNA samples for the mother-newborn study were collected
following informed consent from pregnant mothers enrolled as
patients in the medical practice of Graham Tronc, ObGyn, at
Brisbane Private Hospital. All pregnant mothers in this study were
encouraged to take a vitamin supplement rich in folic acid, either
Blackmore’s Gold Pregnancy, Elevit, or Fefol, but no data on
intake is available. Maternal samples were collected between the
30th and 36th week of pregnancy during regular visits and were
processed through the LeukoLocks by staff of Gribbles Pathology
Associates. Umbilical cord blood samples were processed at birth
by GG or EM, with the majority of deliveries by caesarian section
arranged in advance between the hours of 8am and 11am. All
samples for this study were collected between August 2008 and
February 2009. In order to avoid batch effects, we did not extract
RNA until immediately prior to microarray hybridizations after all
samples had been collected. At this time, we discovered that a
large number of the samples had been affected by significant RNA
degradation with the result that only 56 of the 90 originally
collected samples yielded RNA of minimal acceptable quality for
hybridizations. The cause of the degradation is unknown, but we
suspect a change in the pH of the PBS or RNAlater solutions used
for washes over several months and/or variation in the sealing of
the filters before storage by multiple individuals engaged in the
processing. As a consequence, only 16 mother-newborn pairs were
included in the study, with the remaining 24 samples from only the
mother or baby.
Blood samples for the cross-sectional study were collected with
permission of the Red Cross Society of Australia and under
informed consent from 100 participants (50 men and 50 women)
between the ages of 18 and 68 (mean 44). BMI ranged from
17.7 to 51.3 with a mean of 26.6. Collection was carried out by
EM at mobile Red Cross vans at 10 locations (Bellbowrie,
Capalaba, Dayboro, Eagle Farm, Kenmore, Mount Ommaney,
South Brisbane, St Lucia, Virginia, and Woolloongabba)
distributed across the city, most with multiple sampling days
and 5–10 samples per day, between March and June, 2009.
Each of these samples was also tested for the presence of
antibodies against EBV and CMV using a rapid ImmunoDOT
Mono-G test-strip assay (GenBio, San Diego CA). Individuals
also provided a limited amount of information by written survey
regarding their location of residence, age, gender, weight and
height, and recent pharmaceutical usage. Sample features are
listed in Table S2.
Following extraction of total RNA from the LeukoLock filters
according to manufacturer recommended protocols, the RNA
concentration was estimated with a NanoDrop 1000 spectro-
photomer and quality was assessed with an Agilent Bioanalyzer.
RIN (RNA Integrity Number) scores for the samples included in
the mother-newborn study ranged from 3.2 to 9.3 (median 6.75;
23 samples greater than 7.0). RIN scores for the samples included
in the Red Cross study ranged from 4.9 to 9.5 (median 8.75; 66
samples greater than 8.0).
Flow Cytometry
In order to estimate the relative abundance of cells, flow
cytometry was performed on a BD LSR-II at the Queensland Brain
Institute. EDTA treated whole blood was incubated in FACS Lysing
Solution (BD Biosciences, San Jose, CA) and stained with diagnostic
monoclonal antibodies (BD Biosciences) against seven different cell-
surface Cellular Differentiation antigens: CD3, CD4, CD8, CD16,
CD19, CD45, and CD123. Each batch of samples was kept at room
temperature, and processed the day immediately following blood
collection, such that no samples were frozen or stored for longer than
24 h at room temperature. An unstained control was also tested for
each sample, as well as positive controls for each of the seven
antibodies from one of the samples in each batch.
Cell counts were analyzed using Weasel 2.6.1 software developed
by the Walter and Eliza Hall Institute (Melbourne, Australia)
downloaded from http://en.bio-soft.net/other/WEASEL.html.
Contour plots for pair-wise comparisons of channel intensities were
drawn, and 91.67% densities selected manually. Samples were
included where the sum of CD4+ and CD8+ was within 85% of the
CD3+ count, and where the sum of CD3+, CD16+ and CD19+
cells was greater than 80%. CD4 averaged 14.3% with a standard
deviation of 4.0%, and CD8 averaged 6.7% with a standard
deviation of 3.7%. Similar results were obtained using the
automated gating options with BD’s FACSDiva software.
Gene Expression Profiling
Each RNA sample was reverse transcribed and labeled with
Cy3 dye according to standard Illumina protocols (using 500 ng of
RNA and 14 h incubation for the IVT reaction), and hybridized
to an Illumina HT-12 bead array with over 48,000 probes, each
represented by between 20 and 80 individual beads. Two blocks of
hybridizations were performed, one for each study, a couple of
months apart. Within each study, samples were randomized across
the arrays with respect to maternal or newborn origin of the
sample, or with respect to collection site and location of residence.
Arrays were scanned on an Illumina BeadArray Scanner and data
was extracted with Genome Studio Software. Standard array
quality measures indicated high quality hybridization and all
samples were taken forward for further analysis. The mother-
newborn study included one technical replicate (both samples
cluster adjacent to one another in all subsequent analyses), and the
Red Cross study included six technical replicates (four of which
cluster adjacent to one another, one very close, while fifth was
disparate but in the same broad profile group).
Statistical Analyses
Raw probe summary data was exported into Microsoft Excel
and transformed on the log base 2 scale. Each study was analyzed
separately. In order to reduce the dataset to include only genes
that are expressed above background, we first computed the
average expression level for each probe across all of the samples,
and plotted these averages in rank order. The inflection point of
this curve suggested a conservative cutoff including 15,000 probes
for each study, of which 13,715 (91.4%) representing 10,987
different genes were included in both analyses. The log2 values for
each of the 15,000 probes were then imported into JMP Genomics
4.0 (SAS Institute, Cary NC) for all subsequent analyses. These
values are available as Table S3, and the raw array measures are
available at the Gene Expression Omnibus (GEO) repository as
series GSE21345 with sub-series GSE21311 and GSE21342 for
the Red Cross and Mother-Newborn studies respectively.
JMP Genomics provides a versatile analysis environment with
workflows for performing quality control and data normalization,
supervised and unsupervised clustering, and analysis of variance of
gene expression profiles. Initial exploratory analyses indicated that
the raw data is influenced by a variety of technical artifacts,
principally RNA quality (samples below RIN 6.5 cluster quite
distinctly from those above RIN 6.5), and in the Red Cross study
an array effect that significantly differentiated 5 of the arrays from
Maternal-Fetal Gene Expression
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the other 4 (each array was hybridized with 12 samples). Three
individuals (mother-newborn) and two individuals (Red Cross)
were removed since they had outlying profiles, and after exclusion
of one of the technical replicates where present, 56 and 100
samples were available for analysis.
The following statistical pipeline was adopted. First, the
complete profiles of 15,000 probes per sample were inter-quartile
transformed (we also explored other transformations but did not
observe gross distortion of the conclusions). We then performed
hierarchical clustering and observed that while RNA quality was a
major influence, consistent structure could be seen within the high
and low quality groups, so decided to remove this effect
statistically. We fit an analysis of variance model to each probe
fitting expression as a function of RNA quality with four
approximately equal-sized categorical levels in the mother-
newborn study (RIN,5.3; 5.3,RIN,6.5; 6.5,RIN,7.7;
RIN.7.6) or three categorical levels in the Red Cross study
(RIN,8.0; 7.9,RIN,9; RIN.8.9), as well as the dichotomous
array effect in the Red Cross study. The standardized residuals
from this model were carried further for all subsequent modeling.
Subsequently, we calculated the principal components of the
gene expression profiles, retaining the first 5 PC in each analysis as
documented in the text. One of the outputs of the JMP Genomics
expression workflow is an estimate of the proportion of specified
experimental factors that is explained by each PC. This revealed
that PC2MN in the first study precisely corresponds to the
distinction between mother and newborn, and that PC3 RC in
the second study is contributed in part by the distinction between
inner city and suburban residents. It also showed that neither
RNA quality (RIN score) nor array effects contribute to the
variation in the transformed data, and the body mass index overall
was a very minor component of the variation in either study.
Gene significance was evaluated with a combination of
ANOVA and multiple linear regression. For the mother-newborn
study, probe intensity was modeled as a function of the fixed
categorical contrasts BP1A against BP1B and of Mother against
Newborn, with PC3MN, PC4MN and PC5MN as covariates. For the
Red Cross study, probe intensity was modeled as a function of
PC1RC, PC2RC and PC3RC using the ANOVA routine in JMP
Genomics in the absence of a fixed categorical effect. Axes from
each study were compared simply by correlating the estimated
regression slopes from these analyses for all probes.
Appendix S1 describes a series of additional analyses that were
performed to assess the impact of the RNA integrity transforma-
tion on the principal component analysis. In short, instead of
adjusting the transcript abundance measures for RIN, we
performed two parallel analyses to control for RNA integrity (i)
by only including high RNA quality samples, and (ii) by removing
all probes from the analysis that had a significant RIN effect at
p,0.05. Although the percent variation explained by the top 3 PC
changed slightly, all were clearly conserved across the three
analyses and identified the same gene sets as the major
components of variation. Furthermore, we also conducted an
aggressive normalization including hybridization chip as well as
RIN, and this also reduced the percent variation explained by
PC1MN, but retained it as one of the top three components of the
variance with the same transcripts contributing.
Gene Set Enrichment
Gene set enrichment analyses were performed using a
combination of DAVID functional annotation (reported in
Table 3), KEGG Pathway queries, Ingenuity Pathway Analysis.
In each case we set thresholds for inclusion of between 500 and
800 unique genes, noting that agreement between replicate probes
for the approximately 10% of genes was complete with respect to
sign of effect, and almost always estimated similar magnitudes of
differential expression. Bonferroni adjustments for multiple
comparison testing were used to assess the DAVID pathways,
whereas the KEGG analysis relied on simple gene counts.
Additionally, transcription factor and miRNA binding site
enrichment, along with representation of biological pathways
and drug targets was performed with ToppFun in the ToppGene
suite [22] and is reported in Table S4.
Supporting Information
Appendix S1 Description of alternative analyses that demon-
strate robustness of conclusions to control for RNA integrity.
Found at: doi:10.1371/journal.pone.0014479.s001 (0.47 MB
PDF)
Table S1 Magnitude and significance of differential expression.
Found at: doi:10.1371/journal.pone.0014479.s002 (11.21 MB
XLS)
Table S2 Study design; attributes of study participants discussed
in the text.
Found at: doi:10.1371/journal.pone.0014479.s003 (0.07 MB
XLS)
Table S3 Normalized data for both experiments, as submitted to
GEO.
Found at: doi:10.1371/journal.pone.0014479.s004 (9.14 MB ZIP)
Table S4 ToppFun gene enrichment results.
Found at: doi:10.1371/journal.pone.0014479.s005 (1.15 MB
XLS)
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